Patient Preference Between Cabazitaxel and Docetaxel for First-line Chemotherapy in Metastatic Castration-resistant Prostate Cancer: The CABADOC Trial

Giulia Baciarello, R. Delva, Gwénaëlle Gravis, Youssef Tazi, Philippe Beuzeboc, Marine Gross‐Goupil, Emmanuelle Bompas, Florence Joly, Charlotte Greilsamer, Thierry Nguyen Tan Hon, Philippe Barthélémy, Stéphane Culine, Jean François Berdah, Mathilde Deblock, Raffaele Ratta, Aude Fléchon, Caroline Cheneau, Aline Maillard, Géraldine Martineau, Isabelle Borget, Karim Fizazi